secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvex, Inc. (MOVE)
CIK:        0001734750
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001213900-24-043664
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Movano Health reports Q1 revenue $852k, operating loss $5.8M; closes $24M private placement
--------------------------------------------------------------------------------

- Q1 2024 revenue $852,000 from 5,305 Evie Rings shipped; operating loss $5.8M vs $7.2M a year ago.
- Closed $24.1M private placement on April 4, 2024, including investment from a tier-1 medical device company.
- FDA 510(k) decision for Evie Med Ring pulse oximeter expected July 2024; SpO2 trial RMSE 2.46% (below 3.5% FDA guidance).
- Planning arterial blood pressure study in June using arterial line for continuous data.
- Cash and cash equivalents $2.1M at March 31, 2024; D2C orders paused pending improvements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1734750/000121390024043664/0001213900-24-043664-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1734750/000121390024043664/ea0206242-8k_movano.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-043664

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer